You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 5, May 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antidepressants in Black and White Inpatients

Differential Response to a Controlled Trial of Chlorpromazine and Imipramine

Allen Raskin, PhD; Thomas H. Crook, MA

Arch Gen Psychiatry. 1975;32(5):643-649.


Abstract

Differential effects of chlorpromazine, imipramine hydrochloride, and a placebo were examined in 159 black and 555 white depressed patients in a multihospital collaborative study. In making these comparisons, the effects of age and social class were controlled.

The major study findings were the differential effects of the active drugs for the black men and women. Chlorpromazine was the most efficacious treatment for black women, whereas imipramine was most efficacious for black men. These differences occurred on global ratings of improvement as well as on specific symptoms such as depression, anxiety, guilt-worthlessness, sleep disturbances, and social participation. Black patients also evidenced a higher improvement rate at one week, irrespective of treatment, than did the white patients.



Author Affiliations

From the Psychopharmacology Research Branch, Department of Health, Education and Welfare, Rockville, Md.


Footnotes

Accepted for publication Nov 7, 1974.

Reprint requests to the Psychopharmacology Research Branch, 5600 Fishers Lane, Rm 9-101, Department of Health, Education and Welfare, Rockville, MD 20852.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Interface of Multiculturalism and Psychopharmacology
Rey
Journal of Pharmacy Practice 2006;19:379-385.
ABSTRACT  

Are There Differences Between Women's and Men's Antidepressant Responses?
Quitkin et al.
Am. J. Psychiatry 2002;159:1848-1854.
ABSTRACT | FULL TEXT  

The Pharmacologic Treatment of Anxiety and Depression in African Americans: Considerations for the General Practitioner
Strickland et al.
Arch Fam Med 1997;6:371-375.
ABSTRACT  

The Essential Elements of Culturally Sensitive Psychiatric Services
Bhui et al.
Int J Soc Psychiatry 1995;41:242-256.
ABSTRACT  

Blacks, Schizophrenia, and Neuroleptic Treatment
Stephen
Arch Gen Psychiatry 1992;49:164-165.
ABSTRACT  

American Blacks and Psychiatry
Adebimpe
Transcultural Psychiatry 1984;21:83-111.
 

Cultural Variation in the Responses to Pharmacotherapy and the "Non-Specific" Factors which May Affect This or "We Know All the Answers--It Is the Questions that We Do Not Know"
Joyce
Transcultural Psychiatry 1980;17:129-148.
 

Tricyclic Plasma Levels: Effect of Age, Race, Sex, and Smoking
Ziegler and Biggs
JAMA 1977;238:2167-2169.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.